Decheng Capital Management III (Cayman), LLC

Related Filers (7)

Other (9)

13F-HR/A
Tuesday, 12/12/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Wednesday, 11/29/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 7/28/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/10/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/9/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/8/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/1/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/10/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Show More

Ownership (11)

4
Monday, 1/22/2024
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/27/2022
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/14/2022
Equillium, Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
BeyondSpring Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
Cue Health Inc.: Major Shareholders
SC 13G
Monday, 2/14/2022
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13G
Monday, 2/14/2022
Checkmate Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 9/30/2021
Cue Health Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/23/2021
Cue Health Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/21/2021
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/23/2019
ALPINE IMMUNE SCIENCES, INC.: Initial statement of beneficial ownership of securities
Show More